Meet the challenge of changing stakeholder demands and increasing cost constraints with IQVIA's integrated technology services and analytics-driven offerings.
Receiving Safety reports is a complicated process for many life-science organizations as data volume and complexity continue to increase with information flowing in from multiple global sources. Add in the changing regulations from local and regional agencies and it can become a compliance nightmare for companies. Revising case intake into an optimized, unified process can address these challenges. Technologies such as artificial intelligence (AI) and data automation can simplify the case intake process, while also ensuring quality is improved throughout.
Accessing the right information quickly in drug safety is of critical importance at all stages of drug development. Over half of all safety process activity is manual collation and extraction of data from one format to another – causing higher costs and lower quality. With increasing data volumes and complexity, traditional manual models of identifying AEs, understanding context, and review/case processing are no longer sufficient.
New solutions allow for the automation of the receipt and management of each AE collected providing an accelerated and streamlined intake process and enhanced data consistency. At the recent Safety Seminar in Boston, IQVIA executives delved deeper into IQVIA’s Vigilance platform to examine how integrated tech-enabled services allow life-science organizations to do upfront case processing for improving efficiency, quality and quickly raise queries to enable rapid insights needed for better decision-making.
Multiple technologies and life-science specific developments work together within IQVIA’s Vigilance Platform to simplify case intake and case processing:
Organizations have seen impressive results with these tools. For instance, a Tier 1 pharmaceutical firm processing 450K+ cases across the US, EU and Japan saw improved first-time quality by 20%, and a decrease in cost of data entry and QA by 35%-65% depending on case source. This organization also saw follow-up queries reduced by 30% using IQVIA’s Vigilance Platform.
IQVIA Vigilance modules Detect, Collect and Intake which utilize conversational AI, AI search engines, guided web-forms, intake management tools, and NLP technology, work together to enable organizations to streamline and improve AE and PQC intake to drive cost reductions, time savings and an increase in quality of the AE and PQC intake process.
To learn more about the IQVIA Vigilance Platform, please click here.
Meet the challenge of changing stakeholder demands and increasing cost constraints with IQVIA's integrated technology services and analytics-driven offerings.
Harness the power of automation to execute streamlined end-to-end safety solutions while reducing costs.
IQVIA Vigilance Platform is our secure SaaS environment built to simplify safety and PV processes, while boosting speed, accuracy, and efficiency.
Discover how AI and ML reduce risk and increase efficiency in adverse event reporting